Agree, for growth company investors will be happy to buy around 23 to 25 PE, provided growth is pretty locked in and also rate of growth. As soon as CSL has a clear path to compensate for any revenue losses due to VYVGART, investors will start concentrating on 2025 onwards. Long term growth has to be good when you spend $1B on R&D.
Agree, for growth company investors will be happy to buy around...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$289.10 |
Change
1.140(0.40%) |
Mkt cap ! $139.7B | |||
| Open | High | Low | Value | Volume |
| $288.40 | $289.45 | $287.63 | $178.7M | 622.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 230 | $289.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $289.23 | 328 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$289.06 |
Change
1.140 ( 0.53 %) |
||||
| Open | High | Low | Volume | ||
| $288.42 | $289.39 | $287.61 | 103055 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CSL (ASX) Chart |